-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Sector Perform on Aurinia Pharmaceuticals, Raises Price Target to $18

Benzinga·11/02/2026 14:43:10
Listen to the news
RBC Capital analyst Douglas Miehm maintains Aurinia Pharmaceuticals (NASDAQ:AUPH) with a Sector Perform and raises the price target from $16 to $18.